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LONG-CHAIN N-3 OILS: DOES FARMED AUSTRALIAN FISH REMAIN A
BETTER SOURCE OF THE GOOD OIL THAN WILD-CAUGHT FISH?
P.D. Nichols 1, B. Glencross 2, J.P. Petrie 3, S.P. Singh 3. 1CSIRO Food, Nutrition
& Bioproducts; Oceans & Atmosphere Flagships, TAS, Australia; 2CSIRO
Agriculture Flagship, QLD, Australia; 3CSIRO Agriculture Flagship, ACT,
Australia
E-mail: peter.nichols@csiro.au (P.D. Nichols)
Background/Aims: Seafood contains n-3 long-chain ( 20 carbons)
polyunsaturated fatty acids (LC-PUFA, also termed LCn-3 oils). Humans
biosynthesize only small amounts of LCn-3, so they are considered semi-
essential nutrients in our diet. Concern exists that compared to wild-
caught seafood, farmed ﬁsh contain lower LCn-3 content due to use of non-
marine oil in diets. We determined current LCn-3 content and composition
of farmed Australian ﬁsh and also supplements, as consumers increasingly
seek their LCn-3 from the latter.
Methods: Lipids were extracted by standard methods with fatty acids (FA)
analysed as FA methyl esters by GC and conﬁrmed by GC-MS.
Results: We observed that two major farmed ﬁnﬁsh species, Atlantic
salmon and barramundi, have higher oil and LCn-3 content than the same
or other species from the wild, and remain an excellent source for
obtaining substantial intake of these oils. Notwithstanding, in Australia
(and New Zealand) LCn-3 oil content has decreased in these two farmed
species, largely resulting from the replacement of dietary ﬁsh oil with
poultry oil. For Atlantic salmon, LCn-3 content decreased ~30%e50% be-
tween 2002 and 2013, and the n-3:n-6 ratio also decreased (> 5:1 to < 1:1).
For the supplements compared, all met LCn-3 speciﬁcations.
Conclusions: The development and application of new oilseeds containing
LCn-3 oils, and their incorporation in aquafeeds, will enable the content of
these oils to be maximized in farmed seafood. Such advances can assist
with: ﬁsheries management, aquaculture nutrition, an innovative feed/
food industry and ultimately towards improved consumer health.
Funding source(s): CSIRO.
POTENTIAL FOR LONG CHAIN N-3 PUFA SYNTHESIS IN POULTRY:
CHARACTERISATION OF THE CHICKEN, TURKEY AND DUCK ELONGASE
ENZYMES
M.K. Gregory 1, M.S. Geier 2, M.J. James 1. 1Rheumatology Unit, Royal
Adelaide Hospital, SA, Australia; 2 South Australian Research and
Development Institute, Pig and Poultry Production Institute, Roseworthy,
SA, Australia
E-mail: melissa.gregory@health.sa.gov.au (M.K. Gregory)
Background/Aims: Poultry could be a useful source of non-ﬁsh derived
EPA and DHA if they are capable of synthesizing these n-3 PUFA from di-
etary plant-derived a-linolenic acid. The ability to elongate docosa-
pentaenoic acid (DPA; 22:5n-3) to 24:5n-3 is a crucial and limiting reaction
for synthesis of DHA.We examined the activities of the chicken, turkey and
duck elongase enzymes, Elovl5 and Elovl2.
Methods: Saccharomyces cerevisiae expressing the chicken, turkey or duck
Elovl2orElovl5werecultured in thepresenceofvariousC18-22PUFAsubstrates
to determine the substrate speciﬁcity and dose response of the enzymes.
Results: The turkey and duck Elovl5 activity was limited to C18 and C20
PUFA substrates. The chicken Elovl5 activity was unique compared to
turkey and duck as it also elongated DPA to 24:5n-3 with 20% conversion.
Conversion was undetectable for turkey and duck Elovl5. The duck Elovl2
selectivity was broad with elongation of C18-22 PUFA substrates compared
to the more restricted chicken or turkey Elovl2 selectivity towards C20 and
C22 PUFA substrates only. EPA dose response curves indicate that the duck
Elovl2was the most efﬁcient to catalyse the sequential elongation reaction
EPA to DPA to 24:5n-3.
Conclusions: The combined activity of the chicken Elovl5 and Elovl2 to
convert DPA to 24:5n-3 may enable chickens to synthesize more 24:5n-3
and subsequently more DHA compared with turkey and duck. However,
the duck Elovl2 was particularly active in elongating EPA and DPA to 24:5n-
3 indicating a capability for DHA synthesis that could be exploited.
Funding source(s): N/A.EFFECT OF FISH OIL ON CLINICAL OUTCOMES IN RECENT ONSET
RHEUMATOID ARTHRITIS
M.J. James 1, S.M. Proudman 1, R.G. Metcalf 1, L.D. Spargo 1, T.R.
Sullivan 2, L.G. Cleland 1. 1Rheumatology Unit, Royal Adelaide Hospital, SA,
Australia; 2Discipline of Public Health, University of Adelaide, SA, Australia
E-mail: michael.james@health.sa.gov.au (M.J. James)
Background/Aims: To examine the effect of a ﬁsh oil intervention on
disease control and disease-modifying anti-rheumatic drug (DMARD)
effectiveness in recent onset rheumatoid arthritis (RA) with follow-up
analysis of the relationships between plasma levels of the n-3 fatty acids,
EPA and DHA, and the same outcome measures.
Methods: We conducted a double-blind randomised controlled trial (RCT)
of high dose ﬁsh oil versus control in recent onset RA treated with a rules-
based drug algorithm, responsive to disease activity and toxicity. This
allowed DMARD use (in fact failure of DMARDs to achieve disease control)
to be a primary outcome measure along with remission. As well as the
analysis by treatment group, relationships between plasma EPA and DHA
and the primary outcomes were examined.
Results: Compared to the control group, the ﬁsh oil group had an increased
rate of remission (HR 2.09, 95%CI: 1.02, 4.30, p ¼ 0.04) and decreased rate
of DMARD failure (RR 0.24, 95%CI: 0.10, 0.54, p ¼ 0006). Plasma EPA was
favourably associated with time to remission (HR 1.12, 95%CI: 1.02, 1.23, p
¼ 0.017) and time to DMARD failure (HR 0.85, 95%CI: 0.72, 0.99, p¼ 0.047).
The HRs for DHA and the same outcomes were similar to those for EPA but
not statistically signiﬁcant.
Conclusions: An RCT demonstrated increased ACR remission and decreased
DMARD failure in the ﬁsh oil group. Follow-up analysis was consistent with
the RCT results in demonstrating favourable relationships between plasma
EPA and the sameoutcomemeasures. Anti-inﬂammatory doses ofﬁshoil can
provide adjunctive therapy for standard drug treatment of recent onset RA.
Funding source(s): NHMRC.
BIOAVAILABILITY OF FISH OIL VS KRILL OIL e INFLUENCE OF GENDER
S. Ghasemi Fard 1, G.M. Turchini 2, A.J. Sinclair 1. 1Metabolic Research Unit,
School of Medicine, Deakin University, Geelong, Australia; 2 School of Life
and Environmental Sciences, Deakin University, Warrnambool, Australia
E-mail: sghasemi@deakin.edu.au (S. Ghasemi Fard)
Background/Aims: Krill oil is an alternative source of n-3 fatty acids (FAs).
There are conﬂicting results from the studies comparing the effects of ﬁsh
oil and krill oil.
Objective: The aim of this study was to compare the true bioavailability of
n-3 FAs from ﬁsh oil and krill oil in rats of both genders, using the whole
body fatty acid balance method (WBFABM).
Design: Sprague Dawley rats (36male, 36 female) were randomly assigned
to 6 groups after one week acclimatization, were fed to constant ration for
6 weeks on either a krill oil diet (KO: 10% fat, EPA+DHA¼ 19.8 mg/g of diet)
or a ﬁsh oil diet (FO: 10% fat, EPA+DHA¼ 20.5 mg/g of diet). The faeces and
whole body were analysed for fatty acid content.
Outcomes: Krill oil and ﬁsh oil supplementation led to approximately
similar levels of EPA and DHA in the whole body in both genders. More than
90% of the EPA ingested was b-oxidised in both diets. More than 60% of the
DHA was b-oxidised; which was signiﬁcantly higher in FO than KO. The
amount of DHA deposited was signiﬁcantly more in KO than FO. More than
80% of docosapentaenoic acid was deposited in KO compared with 35% in
FO. In contrast, less than 10% of KOwas b-oxidised comparedwith 60% in FO.
Conclusions: The results suggested that krill oil and ﬁsh oil n-3 FAs have
different metabolic fate.
Funding source(s): Molecular Medicine Strategic Research Centre Deakin
University.
ERYTHROCYTE LONG CHAIN N-3 PUFA LEVEL IS A PREDICTOR OF BODY
WEIGHT STATUS IN OLDER AUSTRALIANS
E.Mingay 1,2,M. Veysey 3,M. Lucock 4, S. Niblett 3, K. King 3, A. Patterson 1,M.L.
Garg 2. 1 School of Health Sciences, University of Newcastle, NSW, Australia;
2Nutraceuticals Research Group, University of Newcastle, NSW, Australia;
3 School of Medicine & Public Health, University of Newcastle, NSW, Australia;
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E-mail: Edwina.Mingay@uon.edu.au (E. Mingay)
Background/Aims: Restricting energy intake for weight management in
older people is neither safe nor practical as nutrient depletion may result
in impairment of an already compromised immune system. Alternative
strategies to combat adiposity without pre-disposing older people to in-
fectious diseases are warranted. n-3PUFA may play an important role
through their impact on increased fat oxidation and reduced inﬂamma-
tion. This study aimed to examine the relationship between n-3PUFA
status and anthropometric measures in an older population.
Methods: Older adults (n ¼ 620; age 65-95 years; 56.3% females) from the
Central Coast region, NSW, Australia were recruited. Anthropometric
measurements, including height, weight, BMI, waist (WC) and hip
circumference (HC) were taken. The fatty acid composition of erythrocyte
membranes was analysed via GC to determine n-3PUFA status (%EPA plus %
DHA).
Results: A negative association was detected between n-3PUFA status and
anthropometric measures: BMI (r ¼ -0.08, p < 0.05), WC (r ¼ -0.08, p <
0.05) and waist-to-hip ratio (WHR; r ¼ -0.143, p < 0.001). Stratiﬁcation of
participants based on ﬁsh oil supplementation status and gender (sup-
plements: n ¼ 169, females 36.7%; no supplements: n ¼ 451, females
53.6%) indicated that these associations were gender speciﬁc. All female
sub-groups displayed a negative association with BMI, WC and WHR that
was signiﬁcant or trending to signiﬁcance (r¼ -0.114 to -0.211). In contrast,
no association between n-3PUFA status and anthropometric measures was
detected in males.
Conclusions: Weight status was negatively associated with n-3PUFA sta-
tus in a sex-dependent manner. Therefore, increased intake of n-3PUFA via
food sources and/or supplementationmay assist with weight management
in older people, particularly women.
Funding source(s): ARC.
N-3 PUFA STATUS PREDICTS NON-ALCOHOLIC FATTY LIVER DISEASE
(NAFLD) IN OLDER AUSTRALIANS
M. Rose 1,2, M. Veysey 3, M. Lucock 4, S. Niblett 1, K. King 3, S. Baines 1,2, M.L.
Garg 2. 1 School of Health Sciences, University of Newcastle, NSW, Australia;
2Nutraceuticals Research Group, University of Newcastle, NSW, Australia;
3 School of Medicine & Public Health, University of Newcastle, NSW,
Australia; 4 School of Environmental & Life Sciences, University of
Newcastle, NSW, Australia
E-mail: Meagan.Rose@uon.edu.au (M. Rose)
Background/Aims: NAFLD is highly prevalent in older people and
currently no speciﬁc drugs are available for treatment. n-3PUFA, known for
their lipid-lowering, anti-inﬂammatory and anti-hypertensive properties,
may have therapeutic potential for the management of NAFLD. The aim of
this study was to determine if a relationship exists between n-3PUFA
status and NAFLD in older Australians.
Methods: Older men and women (n ¼ 620; age 65-95 years) living in
the Central Coast Region of NSW were recruited. Fatty Liver Index (FLI)
scores, used as an indicator of NAFLD, were calculated using a validated
algorithm involving BMI, waist circumference, plasma triglycerides and
g-glutamyl transferase. n-3PUFA status (%EPA plus %DHA) was deter-
mined by analysing fatty acid composition of erythrocyte membranes
by GC.
Results: Following application of exclusion criteria, 481 subjects (females
60.7%; mean ± SD age 78 ± 7 years) were included in the analysis. Of
those, 218 subjects (females, n ¼ 107 or 49.1%) had FLI scores (> 60)
suggestive of NAFLD. n-3PUFA status was signiﬁcantly lower in partici-
pants with NAFLD compared to those NAFLD (p < 0.05). A signiﬁcant
inverse relationship was found between n-3PUFA status and FLI (r ¼
-0.153; p < 0.001). Sex differences were evident, with women but not
men showing a signiﬁcant association between n-3PUFA status and FLI (r
¼ -0.192; p < 0.015).
Conclusions: This study demonstrated a sex-dependent inverse relation-
ship between n-3PUFA status and NAFLD in an older population, paving
the way for an n-3PUFA intervention trial in this high risk age group.
Funding source(s): ARC.BASELINE OMEGA-3 INDEX CORRELATES WITH AGGRESSIVE AND
ATTENTION DEFICIT BEHAVIOURS IN ADULT PRISONERS
B.J. Meyer 1, M.K. Byrne 2, C. Collier 3, N. Parletta 4, D. Crawford 3, P.C.
Winberg 5, D. Webster 1, K. Chapman 3, G. Thomas 3, J. Dally 3, M.
Batterham 6, I. Farquhar 3, L. Grant 7. 1 School of Medicine, University of
Wollongong (UOW), NSW, Australia; 2 School of Psychology, UOW, NSW,
Australia; 3 South Coast Correctional Centre, Nowra, NSW, Australia;
4 School of Population Health, University of South Australia, Australia;
5Venus Shell Systems, NSW, Australia; 6 Statistical Consulting Service, UOW,
Australia; 7NSW Department of Corrective Services, Australia
E-mail: bmeyer@uow.edu.au (B.J. Meyer)
Background/Aims: There is no published data on the omega-3 index in
prison populations in relation to mental health. We aim to determine if the
variance of the baseline omega-3 index is correlated with aggressive and
attention deﬁcit behaviours in a prison population.
Methods: One hundred and thirty six adult male prisoners were recruited
from South Coast Correctional Centre (SCCC), NSW Australia. A 7-point
categorisation was used to quantify levels of aggressive behaviour (four
weeks) from individual SCCC case notes, whereby higher scores corre-
spond to increasingly aggressive behaviour. At baseline, study participants
completed an Aggression Questionnaire (AQ) and the Brown’s Attention
Deﬁcit Disorder Scales (BADDS), provided a blood sample for erythrocyte
fatty acid analysis using GC and the omega-3 index was calculated.
Results: The baseline omega-3 index ranged from 2.3% to 10.3% with a
median of 4.7%, indicating that some participants already had substantial
omega-3 intake. Assessment of aggressive and attention deﬁcit behaviour
shows that there were negative correlations between baseline omega-3
index and baseline aggression categorisation scores (r ¼ 0.21, p ¼ 0.016);
total AQ score (r ¼ 0.234, p ¼ 0.011); Anger (r ¼ 0.222, p ¼ 0.016);
Hostility AQ (r ¼ 0.239, p ¼ 0.009); indirect aggression (r ¼ 0.188 p ¼
0.042); total BADDS (r ¼ 0.263, p ¼ 0.005); Activation (r ¼ 0.224, p ¼
0.016); Attention (r ¼ 0.192, p ¼ 0.043); Effort (r ¼ 0.253, p ¼ 0.007);
Affect (r ¼ 0.330, p < 0.001) and Memory (r ¼ 0.240, p ¼ 0.010).
Conclusions: There is a high variability on baseline omega-3 status of a
NSW prison population, and inmates with lower omega-3 index were
more aggressive and had higher ADD scores.
Funding source(s): UOW, NSW Department of Corrective Services.
DISTINGUISHING THE NUTRITIONAL REQUIREMENTS AND
PHYSIOLOGICAL FATE OF DIETARY EPA AND DHA IN ATLANTIC SALMON
G.M. Turchini 1, J.A. Emery 1, J. Trushenski 2, F. Norambuena 1. 1 School of Life
and Environmental Sciences, Deakin University, VIC, Australia; 2Center for
Fisheries Aquaculture and Aquatic Sciences, Southern Illinois University
Carbondale, USA
E-mail: giovanni.turchini@deakin.edu.au (G.M. Turchini)
Background/Aims: Pushed by environmental concerns and economic
forces, the aquaculture industry is reducing ﬁsh oil utilisation, with posi-
tive effects on the sector’s sustainability, but negative effects on the n-3
long-chain PUFA (n-3LCPUFA) content of ﬁnal products. Aiming at opti-
mising n-3LCPUFA utilisation, the different role and fate of EPA and DHA
must be clariﬁed.
Methods: Juvenile Atlantic salmon were fed eight experimental diets for
14 weeks, before harvesting and analyses. Positive control (PC; ﬁsh oil),
and negative control (NC; tallow) reference diets were compared with 6
tallow based diets supplemented with EPA, DHA, or both, at 50% or 100% of
the concentration observed in PC. Results were analysed by one-way
ANOVA.
Results: Performance results revealedminor, but signiﬁcant, differences. Fillet
fatty acid compositionwas affected by the dietary treatment, with the highest
EPA and DHA concentration (65.4 ± 0.3 and 109.1 ± 2.0 mg/g lipid, respec-
tively)beingobserved inﬁsh fedEPA+DHA100%, and lowest (8.6±0.4 and33.8
± 3.1 mg/g lipid, respectively) in NC. EPA was actively b-oxidised in all treat-
ments (12± 7 to 232± 59 nmol/g/day), whilst DHA b-oxidationwas recorded
only inﬁsh fedDHA100%. Independent fromDHAavailability, in all treatments
EPAwas readily bioconverted towards DHA, i.e. 39.3± 0.4% of dietary EPAwas
bioconverted in ﬁsh fed EPA100%, and 35.8 ± 0.9% in EPA+DHA100%.
